Evidence map›Paper›PMID 34189658›Full record

ArticleMarine biotechnology (New York, N.Y.)2021

Evaluation of the Potential of Marine Algae Extracts as a Source of Functional Ingredients Using Zebrafish as Animal Model for Aquaculture.

M Monteiro, A S Lavrador, R Santos, F Rangel, P Iglesias, M Tárraga, A Couto, C R Serra, C Tafalla, E Da Costa and 5 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Marine biotechnology (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Evaluation of Biorefinery Products FromAquaculture nutrition · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

M MonteiroCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal. mailingmarta@gmail.com.ORCID http://orcid.org/0000-0002-9968-8575
A S LavradorCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
R SantosCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
F RangelCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
P Iglesias, Parque Industrial Base 2000, Lorquí, Murcia, Spain.
M Tárraga, Parque Industrial Base 2000, Lorquí, Murcia, Spain.
A CoutoCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
C R SerraCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
C TafallaInmunología Y Patología de Peces, Centro de Investigación en Sanidad Animal (CISA, INIA), Carretera de Algete a El Casar s/n, 28130, Madrid, Spain.
E Da CostaCentro de Espetrometria de Massa, LAQV-REQUIMTE, Departamento de Química, QOPNA, Universidade de Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal.
M R DominguesCentro de Espetrometria de Massa, LAQV-REQUIMTE, Departamento de Química, QOPNA, Universidade de Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal.
A Oliva-TelesCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
A P CarvalhoCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
P EnesCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
P Díaz-RosalesCentro Interdisciplinar de Investigação Marinha E Ambiental (CIIMAR), Terminal de Cruzeiros Do Porto de Leixões, Universidade Do Porto, Av. General Norton de Matos S/N, 4450-208, Matosinhos, Portugal.
Universidade do Porto · PTRede de Química e Tecnologia · PTUniversidad de Murcia · ESCentro de Investigación en Sanidad Animal

Funding

Fundação para a Ciência e a Tecnologia CESAM (UIDB/50017/2020+UIDP/50017/2020), QOPNA (FCT UID/QUI/00062/2019), LAQV/REQUIMTE (UIDB/50006/2020) and RNEM (LISBOA-01-0145-FEDER-402-022125)Fundação para a Ciência e a Tecnologia PTDC/CVT-WEL/5207/2014Fundação para a Ciência e a Tecnologia SFRH/BD/114995/2016Fundação para a Ciência e a Tecnologia SFRH/BD/131069/2017Fundação para a Ciência e a Tecnologia SFRH/BD/138375/2018Fundação para a Ciência e a Tecnologia UID/Multi/04423/2019 (POCI-01-0145-FEDER-007621)Fundação para a Ciência e a Tecnologia ZEBRALGRE_BM_2019-003
6 · The paper itself

Abstract

Research on immunotherapeutic agents has become a focus for the treatment of fish diseases. The ability of algae to produce secondary metabolites of potential interest as immunotherapeutics has been documented. The present research intended to assess antiviral and antibacterial activities of macro- and microalgae extracts against viral and bacterial pathogens and explore their immunomodulatory potential using zebrafish (Danio rerio) larvae as a model organism. The cytotoxicity and antiviral activity of eight methanolic and ethanolic extracts from two macroalgae (Fucus vesiculosus, Ulva rigida) and two microalgae (Nannochloropsis gaditana, Chlorella sp.) were analyzed in established fish cell lines. Six extracts were selected to evaluate antibacterial activity by disk diffusion and growth inhibition assays. The three most promising extracts were characterized in terms of fatty acid composition, incorporated at 1% into a plant-based diet, and evaluated their effect on zebrafish immune response and intestinal morphology in a short-term feeding trial. All extracts exhibited in vitro antiviral activity against viral hemorrhagic septicemia and/or infectious pancreatic necrosis viruses. Methanolic extracts from F. vesiculosus and U. rigida were richer in saturated fatty acids and exhibited in vitro antibacterial action against several bacteria. Most promising results were obtained in vivo with F. vesiculosus methanol extract, which exerted an anti-inflammatory action when incorporated alone into diets and induced pro-inflammatory cytokine expression, when combined with the other extracts. Moreover, dietary inclusion of the extracts improved intestinal morphology. In summary, the results obtained in this study support the potential of algae as natural sources of bioactive compounds for the aquaculture industry.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntiviral AgentsAquacultureCell LineChlorellaDietFatty AcidsFish DiseasesFucusPlant ExtractsStramenopilesUlvaZebrafishAnti-Bacterial AgentsAnti-Inflammatory AgentsAntiviral AgentsFatty AcidsPlant ExtractsFunctional ingredientsImmunostimulantsMacroalgaeMicroalgaeZebrafish

Identifiers

PMID34189658
OpenAlexW3175979906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.